Childhood teratoma of the ovary is a tumor that starts in ovarian cells that can form different tissues. Most are benign, and many children have no symptoms at first or only mild abdominal pain or a belly mass. Doctors usually find it with an exam and imaging, and early symptoms of childhood teratoma of the ovary can include bloating, feeling full quickly, or sudden pain if the tumor twists. Treatment often involves surgery to remove the tumor and preserve the ovary when possible, and chemotherapy is rarely needed. Survival is excellent for benign tumors and is high even when cancerous types are caught early, and most children return to normal activities after recovery.
Overview
Childhood teratoma of the ovarySymptoms
Childhood teratoma of the ovary can cause belly or pelvic pain, bloating, fullness, or a firm lump. Early symptoms of childhood teratoma of the ovary include nausea, constipation, or frequent urination; sudden severe pain can signal ovarian torsion.
Outlook and prognosis
Most children with childhood teratoma of the ovary do very well after surgery, especially when the tumor is found early. Many keep normal hormone function and future fertility. Follow-up with ultrasound and blood tests helps catch rare recurrences promptly.
Causes and risk factors
Childhood teratoma of the ovary usually arises from early germ cells that grow abnormally; the exact cause is unknown and it’s typically not inherited. Known risks are limited: it occurs mainly in girls/young adolescents. No proven lifestyle or environmental triggers.
Genetic influences
Genetics play a limited role in childhood teratoma of the ovary. Most cases are sporadic, arising from developmental cell changes rather than inherited mutations. Rare familial patterns or syndromes exist, so genetic counseling may be considered if there’s family history.
Diagnosis
Childhood teratoma of the ovary is usually found by exam and pelvic/abdominal ultrasound. MRI or CT refines staging, and blood tumor markers (AFP, beta‑hCG) guide care; final diagnosis of childhood teratoma of the ovary comes from surgical pathology.
Treatment and drugs
Treatment for childhood teratoma of the ovary focuses on safely removing the tumor while preserving healthy ovarian tissue when possible. Surgeons often use minimally invasive techniques; pathology then guides follow‑up. Ongoing care may include monitoring tumor markers and tailored imaging to watch for recurrence.
Symptoms
Childhood teratoma of the ovary can show up in everyday life as belly discomfort, a feeling of fullness, or a waistband that suddenly feels tight. Early symptoms of childhood teratoma of the ovary are often vague, so they’re easy to mistake for a stomach bug or constipation. Symptoms vary from person to person and can change over time. If something keeps coming back or seems to be getting worse, it’s worth checking in with a healthcare professional.
A dull ache or cramping low in the belly can come and go. For some, childhood teratoma of the ovary causes steady discomfort that can worsen with activity. Pain may spread to the back or thigh.
The belly may look rounder, and clothes can fit tighter. A childhood teratoma of the ovary can take up space, making the abdomen feel bloated. Parents might notice a firm area when bathing or dressing a child.
Getting full after a few bites or losing interest in meals can happen when the mass presses on the stomach. Nausea can come along with this. Weight changes are usually small at first.
Upset stomach can occur off and on. Vomiting is more likely with sudden changes like twisting of the ovary.
How people usually first notice Childhood teratoma of the ovary?
Many families first notice something is wrong when a child develops sudden abdominal swelling or a firm, painless lump in the lower belly, sometimes with tummy pain, constipation, or feeling full quickly. In some cases, early puberty signs appear unexpectedly, like breast development or pubic hair well before age 8, which can be a first clue tied to hormone-making tumor tissue. Doctors often first pick up the problem during an exam or ultrasound for belly pain, revealing an ovarian mass; these are typical first signs of childhood teratoma of the ovary and describe how childhood teratoma of the ovary is first noticed.
Types of Childhood teratoma of the ovary
Childhood teratoma of the ovary has a few well-recognized clinical variants, and the type often guides both treatment and outlook. These variants reflect how mature or immature the tumor cells look under the microscope and whether malignant (cancerous) elements are present. Not everyone will experience every type. When people search for types of childhood teratoma of the ovary, they’re usually referring to these established variants and how their symptoms differ.
Mature teratoma
Often called a dermoid cyst, this is the most common and typically benign type in children. Many have no symptoms until the cyst grows and causes pressure, bloating, or one-sided pelvic pain. Sudden, sharp pain can occur if the ovary twists (torsion).
Immature teratoma
This variant contains less-developed (immature) tissue and behaves more aggressively than mature teratomas. Symptoms may include a faster-growing pelvic mass, abdominal fullness, or pain. Blood tests and imaging help stage it and plan treatment.
Teratoma with malignant transformation
Rarely, a mature teratoma can develop a cancerous component within it. People may notice worsening or new symptoms such as persistent pain, increasing mass size, or unexpected weight loss. Treatment usually combines surgery with additional therapies.
Mixed germ cell tumor
In some children, teratoma tissue appears alongside other germ cell tumor types, such as yolk sac elements. Symptoms don’t always look the same for everyone. Doctors use tumor markers and imaging to sort out the mix and tailor care.
What genetics can tell you about symptoms
Some ovarian teratomas in children link to chromosome changes, like extra copies or rearrangements, which can drive faster growth and larger masses. Rare inherited variants in tumor‑suppressor genes (the body’s “brakes”) may raise risks for earlier pain, swelling, or torsion.
Causes and risk factors
The exact cause of childhood teratoma of the ovary is unknown. Having risk factors doesn’t mean you’ll definitely develop the condition. It usually is not inherited, and most cases happen by chance. There are no known lifestyle or environmental causes at this time. Known risk factors for childhood teratoma of the ovary are limited, though it is more common in older children and teens.
Environmental and biological risk factors
Understanding what raises the chances of childhood teratoma of the ovary can help families make sense of a diagnosis. Most cases appear to start from changes in how early egg cells develop before birth, which are body-based and not something anyone caused. Researchers are still exploring how outside influences interact with our inner biology. So far, environmental risk factors for childhood teratoma of the ovary have not been clearly identified.
During early ovarian development, an egg cell can begin dividing on its own and form misplaced tissue growth. This internal, body-based process is a recognized biological explanation for these tumors in children. It is not linked to a child’s actions or family habits.
Subtle missteps as germ cells mature before birth can set the stage for tumor formation. These are developmental changes within the ovary, not caused by anything a parent did during pregnancy. Childhood teratoma of the ovary is thought to arise from these early processes.
Studies so far have not identified consistent environmental risk factors for childhood ovarian teratoma. No specific exposure such as common medicines, infections, or everyday pollutants has shown a clear, repeatable link. Research is ongoing to confirm whether any rare exposures matter.
Prematurity, birth weight, and delivery complications have not shown a stable association with this tumor in children. Some small studies report mixed findings, but results do not align across different groups. At this time, these are not considered established risks.
Genetic risk factors
Most cases of childhood teratoma of the ovary develop without an inherited cause. They often begin when a single egg cell starts dividing on its own, creating tumor cells that carry only maternal DNA; this is a change in the tumor, not a family trait. Understanding the genetic risk factors for childhood teratoma of the ovary can help families see why doctors consider most cases sporadic. Carrying a genetic change doesn’t guarantee the condition will appear.
Usually sporadic: Most cases occur without an inherited mutation or syndrome. A child’s diagnosis of childhood teratoma of the ovary does not mean parents or siblings carry the same risk. Overall inherited risk appears very low.
Egg cell origin: Many teratomas start when a single egg cell begins dividing without fertilization (parthenogenesis). The tumor cells often show only maternal DNA, a sign this change arose in the tumor itself. This helps explain why childhood teratoma of the ovary is usually not passed down.
Tumor-only changes: Extra or missing pieces of chromosomes can be found inside the tumor. These somatic changes help drive growth but are not present in the rest of the body. They do not indicate a family risk.
Subtype differences: Mature and immature teratomas can have different genetic patterns. Mature forms often show maternal-only DNA, while immature tumors may have additional chromosome changes. This affects tumor behavior more than inherited risk.
Rare family clustering: On rare occasions, germ cell tumors occur in more than one relative. This suggests a shared genetic background in some families, but a specific gene for childhood teratoma of the ovary has not been confirmed. If several close relatives have germ cell tumors, clinicians may suggest genetics consultation.
Lifestyle risk factors
Childhood teratoma of the ovary is not caused by lifestyle habits, but day-to-day choices can meaningfully affect recovery, symptom control, and treatment tolerance. In other words, while lifestyle risk factors for Childhood teratoma of the ovary are not causal, habits can influence surgical healing, chemotherapy side effects, and overall well-being. The points below link specific behaviors to concrete effects on symptoms, recovery, and complications. Families should tailor changes with the child’s oncology and surgical teams.
Eating nutrient-dense meals supports wound healing after tumor surgery and helps maintain strength during any chemotherapy. Adequate calories can reduce fatigue and support immune resilience.
Protein-rich foods aid tissue repair after oophorectomy, and iron helps restore blood counts if there is anemia from surgery or treatment. Keeping levels up can reduce dizziness and support activity.
Pain medicines and reduced activity often cause constipation after ovarian surgery. Adequate fiber and hydration ease bowel movements and lessen abdominal strain and discomfort.
Gentle walking when cleared promotes circulation and bowel function after surgery. Gradual conditioning rebuilds stamina and can limit deconditioning during surveillance or treatment.
Risk prevention
There’s no known way to stop childhood teratoma of the ovary from forming, but families can lower the chance of serious problems. Prevention is about lowering risk, not eliminating it completely. The focus is on spotting concerns early and getting timely care to protect the ovary and overall health. Knowing the early symptoms of childhood teratoma of the ovary can help you decide when to seek medical care.
Ongoing lower belly pain, a firm lump, or visible abdominal swelling should be checked. New period changes, early breast development, or peeing more often can also be clues.
If symptoms last more than a couple of weeks, book a visit promptly. A pediatric exam and pelvic ultrasound can find an ovarian mass sooner.
Sudden, severe one-sided lower belly pain with nausea or vomiting needs emergency care. Quick treatment can prevent twisting of the ovary (ovarian torsion) and save ovarian tissue.
Keep routine pediatric visits and mention any belly, menstrual, or urinary changes. Early assessment lowers the risk of complications if a teratoma is present.
Transmission
Childhood teratoma of the ovary isn’t contagious; it can’t be spread through touch, coughs, shared items, or blood. Most cases happen by chance and are not inherited, so there is no known parent-to-child transfer—put simply, genetic transmission of childhood teratoma of the ovary has not been established and the risk to siblings is very low. Rarely, a child may have a separate inherited condition that slightly raises the chance of certain tumors, but that’s not the same as passing on the tumor itself. Children with this diagnosis don’t pose an infection risk to others and don’t need isolation from school or everyday activities.
When to test your genes
Consider genetic testing if a child has a strong family history of ovarian or other germ cell tumors, multiple congenital anomalies, or a known familial cancer syndrome. Testing also helps when a teratoma appears unusually early, is recurrent, or shows atypical features on pathology. Discuss results with a genetics professional to tailor surveillance and treatment.
Diagnosis
You might notice a child with belly pain that comes and goes, a firm swelling, or nausea after play or sports. These everyday signs often prompt a pediatric check-up and an ultrasound to look at the ovaries. Getting a diagnosis is often a turning point toward answers and support. Doctors use several steps in the diagnosis of Childhood teratoma of the ovary, combining imaging, blood tests, and a surgical sample to know exactly what it is and how to treat it.
The doctor asks about pain, periods, nausea, and family history, and gently feels the abdomen for any fullness or tenderness. These clues help decide which tests to run first.
An ultrasound uses sound waves to look for an ovarian mass and its features, like solid parts, fluid, or calcium. It is usually the first imaging test because it is quick and does not use radiation.
Blood tests may include AFP, beta-hCG, and LDH to see if certain tumor markers are elevated. Results can suggest the tumor type and help track response after treatment.
In adolescents who have periods, a urine or blood pregnancy test helps guide safe imaging and treatment choices. This is a routine safety step when an ovarian mass is suspected.
Stages of Childhood teratoma of the ovary
Childhood teratoma of the ovary can be benign or, less often, cancerous; staging is used when the tumor shows malignant features to explain how far it has spread. Different tests may be suggested to help define the stage, such as ultrasound or MRI, blood tests (tumor markers), and what the surgeon and pathologist find during and after surgery. Early symptoms of childhood teratoma of the ovary can be vague—belly swelling, tummy pain, feeling full quickly, or a lump noticed on an exam—so staging relies more on imaging and surgical findings than on symptoms. Staging guides treatment and outlook, rather than describing how fast the condition progresses.
Stage I
The tumor is only in one ovary or both ovaries. There is no spread outside the ovaries.
Stage II
The tumor has spread within the pelvis, such as to nearby tissues or the other pelvic organs. It has not reached the belly lining beyond the pelvis or lymph nodes.
Stage III
The tumor has reached the belly outside the pelvis or nearby lymph nodes. Small spots can be found on the lining of the abdomen or nodes may be enlarged.
Stage IV
The tumor has spread to distant parts of the body, such as the chest (lungs) or the liver tissue. Symptoms may include chest discomfort or trouble breathing if fluid builds up around the lungs.
Outlook and prognosis
Families often want to know how life will change after a child is diagnosed with childhood teratoma of the ovary, and what the next few years might look like. For most children, the outlook is very good, especially when the tumor is found early and fully removed. Doctors call this the prognosis—a medical word for likely outcomes. Many tumors are benign (noncancerous), and even when cancerous elements are present, modern surgery and chemotherapy have led to high cure rates.
Many people ask, “What does this mean for my future?”, and for children with localized tumors, long-term survival is typically excellent. When the tumor is malignant or has spread beyond the ovary, treatment is more intensive, but survival still tends to be high with current protocols. Mortality is uncommon in early-stage disease; risks are higher in advanced cases, fast-growing tumor types, or when diagnosis is delayed. Early care can make a real difference, because prompt surgery reduces complications like ovarian torsion and lowers the chance the tumor will rupture.
Looking at the long-term picture can be helpful. Most children go on to normal growth, school, and play after recovery; fertility is often preserved, especially when surgeons can save part of the ovary. Recurrence is possible, so follow-up visits with exams and imaging are important during the first few years after treatment to watch for early symptoms of childhood teratoma of the ovary, like abdominal swelling or new pain. Talk with your doctor about what your personal outlook might look like, including stage, tumor type, whether one or both ovaries were involved, and any genetic findings that might guide follow-up.
Long-term effects
For many children, childhood teratoma of the ovary is curable, and life after treatment is largely typical. Long-term effects vary widely, depending on tumor type (mature vs. immature), the amount of ovary removed, and whether chemotherapy was needed. Even when early symptoms of childhood teratoma of the ovary resolve after surgery, some effects can show up months or years later. Most people do well with routine follow-up and return to school, sports, and everyday activities.
Many keep normal fertility if one ovary is preserved. Removing both ovaries or certain chemotherapy can reduce egg supply. Pregnancy is still possible for many after treatment.
If both ovaries are removed or damaged, estrogen levels can fall early. This can lead to hot flashes, period changes, and bone thinning over time.
Teratomas can rarely come back in the same or opposite ovary, especially within the first few years. Immature teratomas have a higher recurrence risk than mature ones.
Immature teratomas can sometimes grow or spread beyond the ovary. With modern treatment, long-term survival is high, but careful tracking is important.
How is it to live with Childhood teratoma of the ovary?
Day to day, living with a childhood ovarian teratoma often means navigating uncertainty: waiting for imaging results, planning around surgery, and recovering while keeping up with school and friends. Most teratomas in children are benign and, once removed, kids generally return to regular activities, though follow‑up visits and occasional blood tests or scans can be part of life for a while. Families and caregivers may feel the emotional weight of watchfulness—juggling appointments, time off work, and a child’s understandable worries—yet clear care plans and good communication with the medical team usually restore a reassuring routine. For many, the experience builds confidence: learning the signs that need attention, celebrating milestones in healing, and getting back to sports, play, and everyday joys.
Treatment and drugs
Treatment for childhood teratoma of the ovary focuses on removing the tumor while preserving as much healthy ovarian tissue and future fertility as possible. Surgery is the main treatment; for many children with a mature (noncancerous) teratoma, removal of the tumor alone is often enough, and the remaining ovary can keep working normally. If the tumor shows signs of being cancerous (immature or with malignant areas), doctors may recommend chemotherapy after surgery, and a doctor may adjust your dose to balance benefits and side effects. Care teams also monitor tumor markers and use regular imaging to check for recurrence, especially during the first few years after treatment. Ask your doctor about the best starting point for you, including whether a fertility-sparing approach is suitable and what follow-up schedule to expect.
Non-drug treatment
Children and families facing childhood teratoma of the ovary often worry about surgery, recovery, and future fertility. Non-drug treatments often lay the foundation for safe removal, recovery, and long-term well-being. Options range from fertility-sparing surgery and minimally invasive approaches to careful monitoring, rehabilitation, and emotional support. Your team tailors these steps to the tumor type, your child’s age, and family goals.
In many mature teratomas, surgeons remove the mass while leaving as much healthy ovary as possible. This helps protect hormone function and the chance of future fertility. It can also shorten recovery.
Several small cuts let surgeons remove the teratoma with tiny tools and a camera. This often means less pain and a quicker return to school and activities. Not every case is suited to laparoscopy.
In select cases with a very small, simple mass and no symptoms, doctors may observe over time. Regular check-ins confirm the mass is stable and not affecting the ovary. These non-surgical management options for childhood teratoma of the ovary are chosen carefully and revisited at each visit.
Ultrasound checks look for changes after surgery or during observation. Follow-up scanning helps catch rare recurrence and protects the remaining ovary. Scheduling is tailored to age and tumor features.
Your genes may have an impact on how drugs work for you
Some medicines used for childhood ovarian teratomas are processed differently depending on a child’s genes, which can change how well the drug works or the risk of side effects. Genetic testing can sometimes guide dose choices to improve safety and effectiveness.
Pharmacological treatments
Medicines play a supporting role in childhood teratoma of the ovary, and chemotherapy is used mainly when the tumor is immature, cancerous, or has spread. If you notice early symptoms of childhood teratoma of the ovary like new lower-belly pain or a growing pelvic lump, medicines aren’t the fix—evaluation and surgery are the first steps. Doctors adjust treatment plans regularly to balance controlling the tumor with side effects. Alongside chemotherapy, supportive drugs help prevent nausea, protect blood counts, and ease pain during recovery.
Cisplatin, etoposide, and bleomycin (often called BEP or PEB) are standard drugs when the teratoma is malignant or has mixed germ cell elements. These medicines are given in cycles to kill fast-growing tumor cells and can be curative in many children.
Carboplatin, etoposide, and bleomycin (JEB) may be used instead of cisplatin in some children to lower risks to hearing and kidneys. This approach still targets the cancer effectively while aiming to reduce long-term side effects.
Paclitaxel, ifosfamide, and cisplatin (TIP) can be used if disease persists or returns after first treatment. This combination offers another chance to control childhood teratoma of the ovary with malignant features.
Ondansetron, dexamethasone, and aprepitant help prevent or lessen chemotherapy-related nausea and vomiting. Using these before and after chemo can make treatment days more manageable.
Genetic influences
For most families, genetics seem to play a small role in childhood teratoma of the ovary. These tumors usually arise sporadically, without a clear inherited pattern across generations. The tumor cells themselves can carry DNA changes that happen as the mass forms, but those changes typically aren’t in the rest of the body and aren’t passed on. Family history is one of the strongest clues to a genetic influence. When a child has very early onset, tumors in both ovaries, or features of differences in sex development, doctors may suggest a genetics review; otherwise, genetic testing for childhood teratoma of the ovary isn’t routinely needed. If questions remain, your care team can discuss whether a referral for genetic counseling could help clarify risks for siblings or future pregnancies.
Is Childhood teratoma of the ovary genetic?
Genetics play a limited role in childhood teratoma of the ovary. Most cases are sporadic, arising from developmental cell changes rather than inherited mutations. Rare familial patterns or syndromes exist, so genetic counseling may be considered if there’s family history.
Pharmacogenetics—how genetics influence drug effects
Treatment for childhood teratoma of the ovary is mostly surgical, but some children with immature or mixed germ cell tumors also receive chemotherapy. When medicines are used, inherited differences in drug‑handling genes can affect how a child processes platinum drugs like cisplatin or carboplatin, as well as etoposide and bleomycin, which may change the risk of side effects such as hearing loss, kidney strain, nerve tingling, lung irritation, or very low blood counts. Alongside medical history and kidney function, pharmacogenetic testing for childhood teratoma of the ovary may be considered in select cases, but it isn’t a routine part of care. Current dosing relies mainly on body size and organ function, with close monitoring through blood tests, hearing checks, and breathing assessments so the team can adjust treatment promptly. Testing the tumor’s genes rarely changes drug choices for pure teratomas, though it can help confirm the tumor type if mixed elements are suspected. In short, genetics can inform risk, but day‑to‑day decisions focus on removing the tumor safely and using standard medicines carefully when they’re needed.
Interactions with other conditions
In some children, a tumor like childhood teratoma of the ovary can trigger immune system reactions that affect the brain, most notably anti-NMDA receptor encephalitis, which may cause sudden behavior changes, seizures, or unusual movements that overshadow any pelvic discomfort. Doctors call it a “comorbidity” when two conditions occur together. Rarely, if the teratoma contains thyroid tissue (sometimes called struma ovarii), it can lead to an overactive thyroid, bringing symptoms like a fast heartbeat, sweating, heat intolerance, and unintended weight loss. When chemotherapy is needed for certain tumor types, preexisting kidney, hearing, nerve, or heart issues can shape drug choices and side effects, so the care team will tailor treatment with those in mind. Early symptoms of childhood teratoma of the ovary can overlap with these other conditions, so a child might first be evaluated for anxiety, tics, sleep changes, or fevers before a pelvic mass is discovered. Interactions can look very different from person to person, and many living with childhood teratoma of the ovary have no other illnesses, but when overlaps do happen, clinicians treat the tumor and the related condition together to improve recovery.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of girls who seemed well, then developed a swollen belly or early signs of puberty long before their classmates. Midwives and surgeons wrote brief notes about unusual ovarian “growths” in children, often discovered during emergencies when pain became severe. These early accounts were fragmented, but they pointed to a condition affecting the ovary in childhood that behaved differently from tumors seen in adults.
First described in the medical literature as odd, mixed “monstrous” tumors, these masses were later recognized as teratomas—tumors that can contain several types of tissue such as hair or cartilage. In the 19th and early 20th centuries, pathologists began examining them under the microscope and realized that teratomas in children usually looked less aggressive than similar tumors in adults. Surgeons learned that removing the affected ovary could be lifesaving, yet anesthesia and infection risks limited what could be done.
As medical science evolved, better imaging—first simple X‑rays, then ultrasound in the 1970s and 1980s—allowed doctors to see ovarian teratomas before an operation. This mattered for children, because identifying a likely teratoma could guide a safer surgical plan and help preserve future fertility. Pediatric surgical teams grew more skilled at removing just the tumor or one ovary while protecting the other.
With the rise of tumor markers and careful pathology, specialists separated mature (benign) teratomas from immature forms that carry a risk of spreading. This shift clarified why outcomes differed and steered follow‑up care. In parallel, pediatric oncology advanced combination chemotherapy for malignant germ cell tumors, improving survival when teratomas were part of mixed cancers.
Advances in genetics deepened understanding without changing the basics of care. Researchers learned that many ovarian teratomas arise from germ cells that take a wrong developmental path, and that the biology in children is often distinct from adults. Genetic findings also helped explain rare complications, such as hormone production that can trigger early puberty or, rarely, immune reactions affecting the brain.
In recent decades, awareness has grown that childhood teratoma of the ovary is usually curable when found early and treated with tailored surgery. Multidisciplinary care—radiology, pediatric surgery, oncology, and pathology—has become the norm in many centers. The focus today includes not just removing the tumor, but also safeguarding growth, fertility, and long‑term wellbeing.
Over time, the way the condition has been understood has changed, yet the central lesson has held steady: recognizing early symptoms of childhood teratoma of the ovary and getting prompt evaluation greatly improves outcomes. Ongoing registries and international collaborations continue to refine best practices, aiming for excellent survival with the least impact on a child’s future.